Monograph
M01AE02 - Naproxen |
Propably not porphyrinogenic |
PNP |
Rationale
Metabolised by CYP2C8 and 2E1 0-dealkylation. No data pointing to CYP-induction. Did not induce ALAS1 in rat. Two references consider it safe to use. Considerable clinical evidence of non-porphyrinogenicity.
Chemical description
Tabl 250-1000 mg/d. Analgetic and antiflogistic propionic acid derivative. About 30% is metabolized to 6-0-desmethyl derivative by CYP2E1 and 2C8. Inhibitor of CYP 2E1. No data pointing to CYP-induction South African list: use.
French list: authorized. C.Andersson; patient reports: tolerated (n=10).
IPNet drug reports
Uneventful use reported in 82 patients with acute porphyria.
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
© NAPOS 2025